NCT07634640
Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
Recruiting
EARLY_PHASE1Ages 18–85InterventionalUniversity of FloridaInvestigator-initiated
~70 participants
Updated 2026-06-09 on ClinicalTrials.gov
What's tested:Ferumoxytol infusion
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
detection of inflammation
Measured over 72 hours
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Ellen C Keeley, MD, MS · PRINCIPAL_INVESTIGATOR · University of Florida
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
HFpEF
Exclusion
Renal insufficiency
What this trial measures
- detection of inflammation72 hours